Evidence map›Paper›PMID 25256593›Full record

ArticleJournal of magnetic resonance imaging : JMRI2015

Tumor-induced alterations in lymph node lymph drainage identified by contrast-enhanced MRI.

Alanna Ruddell, Sara B Kirschbaum, Sheila N Ganti, Cheng-Liang Liu, Ryan R Sun, Savannah C Partridge

Abstract read
In one paragraph

Article in Journal of magnetic resonance imaging : JMRI, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Alanna RuddellFred Hutchinson Cancer Research Center, Seattle, WA, USA.
Sara B KirschbaumFred Hutchinson Cancer Research Center, Seattle, WA, USA.
Sheila N GantiDepartment of Comparative Medicine, University of Washington, Seattle, WA, USA.
Cheng-Liang LiuSeattle Cancer Care Alliance, Seattle, WA, USA.
Ryan R SunSeattle Cancer Care Alliance, Seattle, WA, USA.
Savannah C PartridgeSeattle Cancer Care Alliance, Seattle, WA, USA.
Seattle Cancer Care Alliance · USUniversity of Washington · USFred Hutch Cancer Center · US

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Marian Esvelt · 1985 to 2026
$296.4M
Lymph Node Alterations in CancerR01CA068328 · NCI · UNIVERSITY OF WASHINGTON · PI RUDDELL, M ALANNA · 1996 to 2014
$4.5M
NCI NIH HHS P30 CA015704NCI NIH HHS R01 CA068328NCI NIH HHS R01CA68328
6 · The paper itself

Abstract

backgroundTo use high resolution MRI lymphography to characterize altered tumor-draining lymph node (TDLN) lymph drainage in response to growth of aggressive tumors.

methodsSix mice bearing B16-F10 melanomas in one rear footpad were imaged by 3.0 Tesla (T) MRI before and after subcutaneous injection of Gadofosveset trisodium (Gd-FVT) contrast agent into both rear feet. Gd-FVT uptake into the left and right draining popliteal LNs was quantified and compared using Wilcoxon signed-rank test. Fluorescent dextran lymphography compared patterns of LN lymph drainage with the pattern of immunostained lymphatic sinuses by fluorescence microscopy.

resultsTDLNs exhibited greater Gd-FVT uptake than contralateral uninvolved LNs, although this difference did not reach significance (P < 0.06). Foci of contrast agent consistently surrounded the medulla and cortex of TDLNs, while Gd-FVT preferentially accumulated in the cortex of contralateral LNs at 5 and 15 min after injection. Fluorescent dextran lymphography confirmed these distinct contrast agent uptake patterns, which correlated with lymphatic sinus growth in TDLNs.

conclusion3.0T MRI lymphography using Gd-FVT identified several distinctive alterations in the uptake of contrast agent into TDLNs, which could be useful to identify the correct TDLN, and to characterize TDLN lymphatic sinus growth that may predict metastatic potential.

Indexed as

GadoliniumOrganometallic CompoundsAlgorithmsAnimalsCell Line, TumorContrast MediaFemaleImage EnhancementImage Interpretation, Computer-AssistedLymphatic MetastasisLymph NodesMagnetic Resonance ImagingMaleMelanomaMiceMice, Inbred C57BLContrast Mediagadofosveset trisodiumGadoliniumOrganometallic Compoundsalbumingadoliniumlymph nodelymphographymelanomamouse

Identifiers

PMID25256593
PMCPMC5357140
OpenAlexW2132909906

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.